Skip to content

Personalizing MPK Prescription

Personalizing MPK Prescription for Individuals With Transfemoral Amputation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06399471
Enrollment
11
Registered
2024-05-03
Start date
2021-10-25
Completion date
2023-10-02
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transfemoral Amputation

Brief summary

In current clinical prosthetic practice, there is no evidence based method for selecting a microprocessor knee (MPK) joint for a patient with an above the knee amputation. Of individuals with amputation in veteran and service member populations, approximately 35% present with an above the knee amputation. It is well understood in clinical practice that MPKs provide numerous benefits to patients with amputations above the knee including improved gait, safety, comfort, confidence, reduced falls, balance, patient satisfaction and reduced energy expenditure, greater ease in negotiating varying terrains, improvements in multi-tasking and cost effectiveness. Studies that have investigated commercially available MPKs tend to lump all of them together within a single group rather than teasing out individual differences between each knee. Therefore, clinicians are left to rely on their own intuition and past experiences with an MPK when selecting for a patient with an above the knee amputation rather than making their decision based on evidence collected from the specific patient. This may mean that some individuals with an above the knee amputation may not be receiving the best component for them which may delay or inhibit their rehabilitation potential following their amputation.

Interventions

DEVICEMicroprocessor prosthetic knee

Microprocessor prosthetic knees for use in a transfemoral prosthesis

Sponsors

Georgia Institute of Technology
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* A unilateral transfemoral amputation of the lower limb at least six months post fitting of definitive lower extremity prosthesis * Habitual use of a lower extremity prosthesis in daily living activities (based on assessment of a physiatrist and/or prosthetist and patient self-report) * Aged between 18 to 75 years * K3 or K4 level ambulators who can perform all locomotor tasks of interest (based on assessment of a physiatrist and/or prosthetist)

Exclusion criteria

* Individuals with any significant neuromuscular or musculoskeletal disorder or other comorbidity that would interfere with participation (based on assessment of the physiatrist and/or prosthetist and patient self-report) * Individuals who have open wounds on their residual limb * Individuals with known visual impairments that would prevent them from safely operating a prosthesis during over ground walking or ascending stairs (based on assessment of the physiatrist and/or prosthetist and patient self-report) * Individuals with known hearing impairments or who use hearing aids that would prevent them from responding to an auditory instruction (based on assessment of the physiatrist and/or prosthetist and patient self-report) * Individuals who are currently pregnant (based on patient self-report) due to slight risk of falling during experiments

Design outcomes

Primary

MeasureTime frameDescription
Ten Meter Walking Test1 monthSelf selected walking speed over ten meters of walking over ground.
Two Minute Walking Test1 monthSelf selected walking speed over two minutes of walking over ground.
Prosthetic Evaluation Questionnaire (PEQ)1 monthA patient reported survey on perceptions of a prosthesis. Scores range zero to one hundred with zero being representing a negative patient reported outcome and one hundred representing a positive patient reported outcome.

Secondary

MeasureTime frameDescription
Physiological Cost Index1 monthA clinical measure of energy expenditure. This formula consists of working heart minus resting heart rate divided by speed.
Stair Ascent Speed1 monthSelf selected walking speed during stair ascent.
Stair Descent Speed1 monthSelf selected walking speed while descending stairs.
Stance Time Asymmetry Index1 monthStance time asymmetry index measures the percent difference in stance time between the prosthetic and sound side limbs. A value equal to zero is indicative of perfect symmetry. Negative values of ST asymmetry index are indicative of increased time spent on the sound side and positive values are indicative of increased time on the prosthetic side.
Ramp Descent Speed1 monthSelf selected walking speed while descending a 5 degree incline.
Steps Per Day1 monthSteps per day as measured by StepWatch.
Ramp Ascent Speed1 monthSelf selected walking speed while ascending a 5 degree incline.
Narrowing Beam Walking Test1 monthA measure of balance via walking down a narrowing beam.
Reported Falls1 monthAverage reported falls per day.

Countries

United States

Participant flow

Pre-assignment details

Knee condition order was randomized prior to enrollment.

Participants by arm

ArmCount
Study Microprocessor Prosthetic Knee
Randomization to C-Leg 4.0, Rheo Knee and Power Knee
11
Total11

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicStudy Microprocessor Prosthetic Knee
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Age, Continuous49.5 years
STANDARD_DEVIATION 10.4
AMPnoPro38.1 units on a scale
STANDARD_DEVIATION 3.9
Clinically Prescribed Prosthetic Knee
Otto Bock C-Leg
7 Participants
Clinically Prescribed Prosthetic Knee
Otto Bock X3
1 Participants
Clinically Prescribed Prosthetic Knee
Plie
2 Participants
Clinically Prescribed Prosthetic Knee
Proteor Quattro
1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Height1.75 Meters
STANDARD_DEVIATION 0.11
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
8 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
3 Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
9 Participants
Weight82.5 Kilograms
STANDARD_DEVIATION 16.3

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 100 / 11
other
Total, other adverse events
0 / 100 / 100 / 11
serious
Total, serious adverse events
0 / 100 / 100 / 11

Outcome results

Primary

Prosthetic Evaluation Questionnaire (PEQ)

A patient reported survey on perceptions of a prosthesis. Scores range zero to one hundred with zero being representing a negative patient reported outcome and one hundred representing a positive patient reported outcome.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedProsthetic Evaluation Questionnaire (PEQ)Power Knee69.4 units on a scaleStandard Deviation 8.99
Prosthetic Knee RandomizedProsthetic Evaluation Questionnaire (PEQ)C-Leg 4.083.2 units on a scaleStandard Deviation 10.15
Prosthetic Knee RandomizedProsthetic Evaluation Questionnaire (PEQ)Rheo78.4 units on a scaleStandard Deviation 11.75
Comparison: The Non-parametric Friedman's test was used to compare the survey results between the participants using the Power Knee and the C-Leg 4.0.p-value: 0.006Non-parametric Friedman's test with mult
Comparison: The Non-parametric Friedman's test was used to compare the survey results between the participants using the Power Knee and the Rheo.p-value: 0.236Non-parametric Friedman's test with mult
Comparison: The Non-parametric Friedman's test was used to compare the survey results between the participants using the Rheo and the C-Leg 4.0.p-value: 0.118Non-parametric Friedman's test with mult
Primary

Ten Meter Walking Test

Self selected walking speed over ten meters of walking over ground.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedTen Meter Walking TestRheo1.1111 Meters per secondStandard Deviation 0.201
Prosthetic Knee RandomizedTen Meter Walking TestPower Knee0.9963 Meters per secondStandard Deviation 0.2061
Prosthetic Knee RandomizedTen Meter Walking TestC-Leg 4.01.1051 Meters per secondStandard Deviation 0.2081
Comparison: An ANOVA was used to compare the Power Knee and the C-Leg 4.0 when used during Ten Meter Walking Test.p-value: 0.126ANOVA
Comparison: An ANOVA was used to compare the Power Knee and the Rheo when used during Ten Meter Walking Test.p-value: 0.015ANOVA
Comparison: An ANOVA was used to compare the Rheo and the C-Leg 4.0 when used during Ten Meter Walking Test.p-value: 0.852ANOVA
Primary

Two Minute Walking Test

Self selected walking speed over two minutes of walking over ground.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedTwo Minute Walking TestC-Leg 4.01.2106 Meters per secondStandard Deviation 0.2025
Prosthetic Knee RandomizedTwo Minute Walking TestPower Knee1.073 Meters per secondStandard Deviation 0.2415
Prosthetic Knee RandomizedTwo Minute Walking TestRheo1.1698 Meters per secondStandard Deviation 0.2458
Comparison: An ANOVA was used to compare the Power Knee and the C-Leg 4.0 when used during Two Meter Walking Test.p-value: 0.003ANOVA
Comparison: An ANOVA was used to compare the Power Knee and the Rheo when used during Two Meter Walking Test.p-value: 0.027ANOVA
Comparison: An ANOVA was used to compare the Rheo and the C-Leg 4.0 when used during Two Meter Walking Test.p-value: 0.425ANOVA
Secondary

Narrowing Beam Walking Test

A measure of balance via walking down a narrowing beam.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedNarrowing Beam Walking TestPower Knee11.3 FeetStandard Deviation 3.14
Prosthetic Knee RandomizedNarrowing Beam Walking TestC-Leg 4.012.6 FeetStandard Deviation 2.8
Prosthetic Knee RandomizedNarrowing Beam Walking TestRheo13.5 FeetStandard Deviation 2.64
Comparison: An ANOVA was used to compare the Power Knee, the C-Leg 4.0, and Rheo when used during the Narrowing beam walking test.p-value: 0.082ANOVA
Secondary

Physiological Cost Index

A clinical measure of energy expenditure. This formula consists of working heart minus resting heart rate divided by speed.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedPhysiological Cost IndexPower Knee0.29 Heart beats per meterStandard Deviation 0.1034
Prosthetic Knee RandomizedPhysiological Cost IndexC-Leg 4.00.25 Heart beats per meterStandard Deviation 0.0593
Prosthetic Knee RandomizedPhysiological Cost IndexRheo0.27 Heart beats per meterStandard Deviation 0.0984
Comparison: An ANOVA was used to compare the Physiological cost index for when the Power Knee, the C-Leg 4.0, and the Rheo were used.p-value: 0.535ANOVA
Secondary

Ramp Ascent Speed

Self selected walking speed while ascending a 5 degree incline.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedRamp Ascent SpeedPower Knee0.8929 Meters per secondStandard Deviation 0.1533
Prosthetic Knee RandomizedRamp Ascent SpeedC-Leg 4.00.969 Meters per secondStandard Deviation 0.2086
Prosthetic Knee RandomizedRamp Ascent SpeedRheo0.971 Meters per secondStandard Deviation 0.1754
Comparison: An ANOVA was used to compare the Ramp Ascent Speed between the Power Knee and the C-Leg 4.0.p-value: 0.144ANOVA
Comparison: An ANOVA was used to compare the Ramp Ascent Speed between the Power Knee and the Rheo.p-value: 0.024ANOVA
Comparison: An ANOVA was used to compare the Ramp Ascent Speed between the Rheo and the C-Leg 4.0.p-value: 0.949ANOVA
Secondary

Ramp Descent Speed

Self selected walking speed while descending a 5 degree incline.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedRamp Descent SpeedPower Knee0.7643 Meters per secondStandard Deviation 0.1675
Prosthetic Knee RandomizedRamp Descent SpeedC-Leg 4.00.869 Meters per secondStandard Deviation 0.2282
Prosthetic Knee RandomizedRamp Descent SpeedRheo0.8584 Meters per secondStandard Deviation 0.2436
Comparison: An ANOVA was used to compare the Ramp Descent Speed for the Power Knee, C-Leg 4.0, and the Rheo when used.p-value: 0.051ANOVA
Secondary

Reported Falls

Average reported falls per day.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedReported FallsRheo0.01429 Falls per dayStandard Deviation 0.04286
Prosthetic Knee RandomizedReported FallsPower Knee0.06429 Falls per dayStandard Deviation 0.10326
Prosthetic Knee RandomizedReported FallsC-Leg 4.00.04286 Falls per dayStandard Deviation 0.06547
Comparison: An ANOVA was used to compare the reported falls when for when the Power Knee, C-Leg 4.0, and the Rheo were used.p-value: 0.943ANOVA
Secondary

Stair Ascent Speed

Self selected walking speed during stair ascent.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedStair Ascent SpeedPower Knee50.463 Steps per minuteStandard Deviation 7.9767
Prosthetic Knee RandomizedStair Ascent SpeedC-Leg 4.056.336 Steps per minuteStandard Deviation 17.494
Prosthetic Knee RandomizedStair Ascent SpeedRheo48.336 Steps per minuteStandard Deviation 7.1067
Comparison: An ANOVA was used to compare the Stair Ascent Speed for the Power Knee, C-Leg 4.0, and the Rheo when used.p-value: 0.229ANOVA
Secondary

Stair Descent Speed

Self selected walking speed while descending stairs.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedStair Descent SpeedPower Knee92.65 Steps per minuteStandard Deviation 25.67
Prosthetic Knee RandomizedStair Descent SpeedC-Leg 4.093.997 Steps per minuteStandard Deviation 27.183
Prosthetic Knee RandomizedStair Descent SpeedRheo88.3 Steps per minuteStandard Deviation 21.261
Comparison: An ANOVA was used to compare the Stair Descent Speed for the Power Knee, C-Leg 4.0, and the Rheo when used.p-value: 0.528ANOVA
Secondary

Stance Time Asymmetry Index

Stance time asymmetry index measures the percent difference in stance time between the prosthetic and sound side limbs. A value equal to zero is indicative of perfect symmetry. Negative values of ST asymmetry index are indicative of increased time spent on the sound side and positive values are indicative of increased time on the prosthetic side.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedStance Time Asymmetry IndexPower Knee-10.15 percentage of stance timeStandard Deviation 3.68
Prosthetic Knee RandomizedStance Time Asymmetry IndexC-Leg 4.0-10.95 percentage of stance timeStandard Deviation 9.98
Prosthetic Knee RandomizedStance Time Asymmetry IndexRheo-7.03 percentage of stance timeStandard Deviation 8.13
Comparison: An ANOVA was used to compare the Power Knee, the C-Leg 4.0, and the Rheo when used during Stance Time Asymmetry Index test.p-value: 0.687ANOVA
Secondary

Steps Per Day

Steps per day as measured by StepWatch.

Time frame: 1 month

Population: 1 participant did not complete any of the conditions due to self withdrawal after consenting.~No data obtained from two participants due to experimental error.~Each participant wore all three knees during this trial.

ArmMeasureGroupValue (MEAN)Dispersion
Prosthetic Knee RandomizedSteps Per DayPower Knee2620.1 Steps per dayStandard Deviation 705.5
Prosthetic Knee RandomizedSteps Per DayC-Leg 4.02762.6 Steps per dayStandard Deviation 969.2
Prosthetic Knee RandomizedSteps Per DayRheo2462.6 Steps per dayStandard Deviation 1030.2
Comparison: An ANOVA was used to compare the Steps per Day for the Power Knee, C-Leg 4.0, and the Rheo when used.p-value: 0.367ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026